With this success, however, came a new challenge, as breakthrough varicella disease received increasing attention from both public health officials and the general population. Prelicensure efficacy trials of a single dose of the vaccine had documented virtually 100% effectiveness in preventing moderate to severe varicella disease, and 80%–85% efficacy in the prevention of any varicella […]
-
Archives
- June 2016
- February 2016
- September 2015
- February 2015
- November 2014
- October 2014
- September 2014
- August 2014
- June 2014
- April 2014
- May 2013
- January 2013
- December 2012
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010